Propentofylline

DB06479ExperimentalSmall molecule

Investigated for use/treatment in alzheimer's disease.

Chemical structure of Propentofylline
Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in alzheimer's disease.Curator reviewed
Formula / weight
C15H22N4O3 · 306.3602 g/mol (avg)
Code names
HWA-285

Resolves to

Clinical / RWD
Structure
InChIKeyRBQOQRRFDPXAGN-UHFFFAOYSA-NSMILESCCCN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
607Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 15 drug categories
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Propentofylline, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account